comparemela.com

Latest Breaking News On - Jason bussgang - Page 1 : comparemela.com

QurAlis Presents Data About STATHMIN-2 Role in Neuronal Disease Biology and TDP-43 Biomarker Identification at AD/PD™ 2022

/PRNewswire/ QurAlis Corporation, a biotech company developing breakthrough precision medicines for amyotrophic lateral sclerosis (ALS) and other.

United kingdomComunidad autonoma de catalunaSandy hinckleyJason bussgangYasmin hamwiMarisa kamelgarnKevin egganTaylor grayDaniel elbaumEggan labPrnewswire quralis corporationAlis corporationDiseases conferenceGolgi apparatus morphologyNeurite outgrowthHuman cortical

QurAlis Presents Data About STATHMIN-2 Role in Neuronal Disease Biology and TDP-43 Biomarker Identification at AD/PD™ 2022

QurAlis Presents Data About STATHMIN-2 Role in Neuronal Disease Biology and TDP-43 Biomarker Identification at AD/PD™ 2022 - read this article along with other careers information, tips and advice on BioSpace

United kingdomComunidad autonoma de catalunaSandy hinckleyJason bussgangYasmin hamwiMarisa kamelgarnKevin egganTaylor grayDaniel elbaumHarvard universityHarvard medical schoolEggan labQuralis corporationPrnewswire quralis corporationAlis corporationDiseases conference

QurAlis Presents Data About STATHMIN-2 Role in Neuronal Disease Biology and TDP-43 Biomarker Identification at AD/PD™ 2022

/PRNewswire/ QurAlis Corporation, a biotech company developing breakthrough precision medicines for amyotrophic lateral sclerosis (ALS) and other.

United kingdomComunidad autonoma de catalunaSandy hinckleyJason bussgangYasmin hamwiMarisa kamelgarnKevin egganTaylor grayDaniel elbaumEggan labPrnewswire quralis corporationAlis corporationDiseases conferenceGolgi apparatus morphologyNeurite outgrowthHuman cortical

QurAlis Presents Data About STATHMIN-2 Role in Neuronal Disease Biology and TDP-43 Biomarker Identification at AD/PD™ 2022

Connection between STATHMIN-2, TDP-43, and ALS cell biology led to discovery of Company s approach and lead development candidate in ALSUpdated da.

United kingdomComunidad autonoma de catalunaSandy hinckleyJason bussgangYasmin hamwiMarisa kamelgarnKevin egganTaylor grayDaniel elbaumHarvard universityHarvard medical schoolEggan labQuralis corporationPrnewswire quralis corporationAlis corporationDiseases conference

QurAlis Presents New Data Confirming Role of STATHMIN-2 in Neuronal Disease Biology at 32nd International Symposium on ALS/MND

/PRNewswire/ QurAlis Corporation, a biotech company developing breakthrough precision medicines for amyotrophic lateral sclerosis (ALS) and other.

United kingdomJason bussgangErika norabuenaYasmin hamwiJames chowKevin egganQurali asosSandy hinckleyMarisa kamelgarnDaniel elbaumTaylor grayInternational symposiumQuralis corporationEggan labTime courseProtein abundance

vimarsana © 2020. All Rights Reserved.